{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "10657478", "DateCompleted": {"Year": "2000", "Month": "05", "Day": "31"}, "DateRevised": {"Year": "2006", "Month": "11", "Day": "15"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0143-4179", "JournalIssue": {"Volume": "33", "Issue": "2", "PubDate": {"Year": "1999", "Month": "Apr"}}, "Title": "Neuropeptides", "ISOAbbreviation": "Neuropeptides"}, "ArticleTitle": "Effects of ginsenosides injected intrathecally or intracerebroventricularly on antinociception induced by beta -endorphin administered intracerebroventricularly in the mouse.", "Pagination": {"StartPage": "101", "EndPage": "106", "MedlinePgn": "101-6"}, "Abstract": {"AbstractText": ["The effect of total saponin fraction of ginseng injected intrathecally (i.t.) or intracerebroventricularly (i.c.v.) on the antinociception induced by beta-endorphin administered i.c.v. was studied in ICR mice in the present study. The antinociception was assessed by the tail-flick test. Total saponin fraction at doses 0.1 to 1.0 microgram, which administered i.t. alone did not affect the latencies of tail-flick threshold, attenuated dose-dependently the inhibition of the tail-flick response induced by i.c.v. administered beta-endorphin (1 microgram). However, total saponin fraction at doses 1 to 20 microgram, which administered i.c.v. alone did not affect the latencies of the tail-flick response, did not affect i.c.v. administered beta-endorphiun (1 microgram)-induced antinociception. The duration of antagonistic action of total saponin fraction against beta-endorphin-induced antinociception lasted at least for 6 h. Various doses (from 0.1 to 1 microgram) of ginsenoside R(c), but not R(b2), R(d), Rg(1), R(b1)and R(e)injected i.t. dose-dependently attenuated antinociception induced by beta-endorphin administered i.c.v. Our results indicate that total saponin fraction injected spinally appears to have antagonistic action against the antinociception induced by supraspinally applied beta-endorphin. Ginsenoside R(c)appears to be responsible for blocking i.c.v. administered beta-endorphin-induced antinociception. On the other hand, total ginseng fraction, at supraspinal sites, may not exert an antagonistic action against the antinociception induced by supraspinally administered beta-endorphin."], "CopyrightInformation": "Copyright 1999 Harcourt Brace & Co. Ltd."}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Institute of Natural Medicine, College of Medicine, Hallym University, Kangwon-Do, 200-702, S. Korea. hwsuh@sun.hallym.ac.kr"}], "Identifier": [], "LastName": "Suh", "ForeName": "H W", "Initials": "HW"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Song", "ForeName": "D K", "Initials": "DK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Huh", "ForeName": "S O", "Initials": "SO"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "Y H", "Initials": "YH"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Neuropeptides", "NlmUniqueID": "8103156", "ISSNLinking": "0143-4179"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Analgesics"}, {"RegistryNumber": "0", "NameOfSubstance": "Central Nervous System Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Ginsenosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Saponins"}, {"RegistryNumber": "60617-12-1", "NameOfSubstance": "beta-Endorphin"}], "MeshHeadingList": [{"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Analgesics"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Central Nervous System Agents"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Cerebral Ventricles"}, {"QualifierName": [], "DescriptorName": "Ginsenosides"}, {"QualifierName": [], "DescriptorName": "Injections, Intraventricular"}, {"QualifierName": [], "DescriptorName": "Injections, Spinal"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred ICR"}, {"QualifierName": ["physiopathology"], "DescriptorName": "Pain"}, {"QualifierName": [], "DescriptorName": "Panax"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Saponins"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Spinal Cord"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "beta-Endorphin"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2000", "Month": "2", "Day": "5", "Hour": "9", "Minute": "0"}, {"Year": "2000", "Month": "6", "Day": "3", "Hour": "9", "Minute": "0"}, {"Year": "2000", "Month": "2", "Day": "5", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10657478", "10.1054/npep.1999.0003", "S0143-4179(99)90003-3"]}}], "PubmedBookArticle": []}